165 related articles for article (PubMed ID: 34822853)
21. Fibulin-7 C-terminal fragment and its active synthetic peptide suppress choroidal and retinal neovascularization.
Ikeuchi T; Kanan Y; Long D; de Vega S; Hozumi K; Nomizu M; Campochiaro PA; Yamada Y
Microvasc Res; 2020 May; 129():103986. PubMed ID: 32017943
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of Lenvatinib, a multitargeted tyrosine kinase inhibitor, on laser-induced CNV mouse model of neovascular AMD.
Wei X; Zhang T; Yao Y; Zeng S; Li M; Xiang H; Zhao C; Cao G; Li M; Wan R; Yang P; Yang J
Exp Eye Res; 2018 Mar; 168():2-11. PubMed ID: 29284110
[TBL] [Abstract][Full Text] [Related]
23. Endothelial microRNA-150 is an intrinsic suppressor of pathologic ocular neovascularization.
Liu CH; Sun Y; Li J; Gong Y; Tian KT; Evans LP; Morss PC; Fredrick TW; Saba NJ; Chen J
Proc Natl Acad Sci U S A; 2015 Sep; 112(39):12163-8. PubMed ID: 26374840
[TBL] [Abstract][Full Text] [Related]
24. Exosome-mediated delivery of an anti-angiogenic peptide inhibits pathological retinal angiogenesis.
Dong X; Lei Y; Yu Z; Wang T; Liu Y; Han G; Zhang X; Li Y; Song Y; Xu H; Du M; Yin H; Wang X; Yan H
Theranostics; 2021; 11(11):5107-5126. PubMed ID: 33859737
[No Abstract] [Full Text] [Related]
25. Regulation of ocular angiogenesis by Notch signaling: implications in neovascular age-related macular degeneration.
Ahmad I; Balasubramanian S; Del Debbio CB; Parameswaran S; Katz AR; Toris C; Fariss RN
Invest Ophthalmol Vis Sci; 2011 May; 52(6):2868-78. PubMed ID: 21228388
[TBL] [Abstract][Full Text] [Related]
26. Disruption of profilin1 function suppresses developmental and pathological retinal neovascularization.
Gau D; Vignaud L; Allen A; Guo Z; Sahel J; Boone D; Koes D; Guillonneau X; Roy P
J Biol Chem; 2020 Jul; 295(28):9618-9629. PubMed ID: 32444495
[TBL] [Abstract][Full Text] [Related]
27. Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis.
Gong Y; Shao Z; Fu Z; Edin ML; Sun Y; Liegl RG; Wang Z; Liu CH; Burnim SB; Meng SS; Lih FB; SanGiovanni JP; Zeldin DC; Hellström A; Smith LEH
EBioMedicine; 2016 Nov; 13():201-211. PubMed ID: 27720395
[TBL] [Abstract][Full Text] [Related]
28. Topical application of a G-Quartet aptamer targeting nucleolin attenuates choroidal neovascularization in a model of age-related macular degeneration.
Leaderer D; Cashman SM; Kumar-Singh R
Exp Eye Res; 2015 Nov; 140():171-178. PubMed ID: 26368850
[TBL] [Abstract][Full Text] [Related]
29. A potential therapeutic strategy for inhibition of ocular neovascularization with a new endogenous protein: rhEDI-8t.
Zhang L; Shen X; Lu Q; Zhou Q; Gu J; Gan R; Zhang H; Sun X; Xie B
Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):731-9. PubMed ID: 21881847
[TBL] [Abstract][Full Text] [Related]
30. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
[TBL] [Abstract][Full Text] [Related]
31. FGF21 Administration Suppresses Retinal and Choroidal Neovascularization in Mice.
Fu Z; Gong Y; Liegl R; Wang Z; Liu CH; Meng SS; Burnim SB; Saba NJ; Fredrick TW; Morss PC; Hellstrom A; Talukdar S; Smith LE
Cell Rep; 2017 Feb; 18(7):1606-1613. PubMed ID: 28199833
[TBL] [Abstract][Full Text] [Related]
32. Effect of brimonidine on retinal and choroidal neovascularization in a mouse model of retinopathy of prematurity and laser-treated rats.
Kusari J; Padillo E; Zhou SX; Bai Y; Wang J; Song Z; Zhu M; Le YZ; Gil DW
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5424-31. PubMed ID: 21482645
[TBL] [Abstract][Full Text] [Related]
33. [Intraocular antiangiogenic drugs in clinical application advantages and disadvantages].
Li XX
Zhonghua Yan Ke Za Zhi; 2012 Oct; 48(10):870-3. PubMed ID: 23302238
[TBL] [Abstract][Full Text] [Related]
34. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration.
Lee JY; Chung H; Kim HC
Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799
[TBL] [Abstract][Full Text] [Related]
35. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac).
Yoshida T; Gong J; Xu Z; Wei Y; Duh EJ
Exp Eye Res; 2012 Jan; 94(1):41-8. PubMed ID: 22123068
[TBL] [Abstract][Full Text] [Related]
37. Suppression of retinal neovascularization by intravitreal injection of cryptotanshinone.
Yu Y; Qin X; Chen X; Nie H; Li J; Yao J
Biochem Biophys Res Commun; 2024 Aug; 720():150065. PubMed ID: 38749188
[TBL] [Abstract][Full Text] [Related]
38. Agents that bind annexin A2 suppress ocular neovascularization.
Lima e Silva R; Shen J; Gong YY; Seidel CP; Hackett SF; Kesavan K; Jacoby DB; Campochiaro PA
J Cell Physiol; 2010 Nov; 225(3):855-64. PubMed ID: 20607799
[TBL] [Abstract][Full Text] [Related]
39. Apratoxin S4 Inspired by a Marine Natural Product, a New Treatment Option for Ocular Angiogenic Diseases.
Qiu B; Tan A; Veluchamy AB; Li Y; Murray H; Cheng W; Liu C; Busoy JM; Chen QY; Sistla S; Hunziker W; Cheung CMG; Wong TY; Hong W; Luesch H; Wang X
Invest Ophthalmol Vis Sci; 2019 Jul; 60(8):3254-3263. PubMed ID: 31361305
[TBL] [Abstract][Full Text] [Related]
40. THE RAP STUDY, REPORT TWO: The Regional Distribution of Macular Neovascularization Type 3, a Novel Insight Into Its Etiology.
Haj Najeeb B; Deak G; Schmidt-Erfurth U; Gerendas BS
Retina; 2020 Dec; 40(12):2255-2262. PubMed ID: 32032256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]